Are you Dr. Przepiorka?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 65 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1331 Union Ave
Suite 800
Memphis, TN 38104Phone+1 901-725-1785Fax+1 901-725-5264
Summary
- Dr. Donna Przepiorka, MD is an oncologist in Memphis, Tennessee. She is currently licensed to practice medicine in Tennessee.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1984 - 1987
Johns Hopkins UniversityResidency, Internal Medicine, 1980 - 1984
University of Illinois College of MedicineClass of 1980
Certifications & Licensure
TN State Medical License 2002 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 12 citationsFDA Approval Summary: Belumosudil for Adult and Pediatric Patients 12 Years and Older with Chronic GvHD after Two or More Prior Lines of Systemic Therapy.Donna Przepiorka, Robert Q Le, Alexei Ionan, Ruo-Jing Li, Ying-Hong Wang
Clinical Cancer Research. 2022-06-13 - 535 citationsIBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADEPhilip A. Rowlings, Donna Przepiorka, John P. Klein, Robert Peter Gale, Passweg
British Journal of Haematology. 1997-06-01 - 80 citationsSyndrome of Idiopathic Hyperammonemia after High-Dose Chemotherapy: Review of Nine CasesR. Brian Mitchell, John E. Wagner, Judith E. Karp, Alan Watson, Saul W. Brusilow
The American Journal of Medicine. 1988-11-01
Press Mentions
Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort StudyMarch 15th, 2016
Guidelines for Preventing Opportunistic Infections Among Hematopoietic Stem Cell Transplant RecipientsSeptember 24th, 2019
